Skip to content
Toggle navigation
PLx Pharma Inc.
About PLx
Company Overview
Management Team
Board of Directors
Scientific Advisory Board
Partnership Opportunities
Products & Technology
PLxGuard Delivery System
PLxGuard Pipeline
Aspertec 325 mg
PL1100/PL1200 Ibuprofen
Publications and Research
Healthcare Professionals
Investors
News & Events
Corporate Governance
Financial Information
Shareholder Services
Contact
The PLxGuard Delivery System has the Potential to Improve Both New and Existing Drugs
Learn about the PLxGuard Delivery System
Home
›
Publications and Research
Publications and Research
2017
Enteric Coating and Aspirin Nonresponsiveness in Patients With Type 2 Diabetes Mellitus
Unlocking Aspirin’s Chemopreventive Activity: Role of Irreversibly Inhibiting Platelet Cyclooxygenase-1
2016
Antitumor and Antiangiogenic Effects of Aspirin-PC in Ovarian Cancer
2010
Low-dose aspirin-induced ulceration is attenuated by aspirin-phosphatidylcholine: a randomized clinical trial.
2008
Clinical trial: comparison of ibuprofen-phosphatidylcholine and ibuprofen on the gastrointestinal safety and analgesic efficacy in osteoarthritic patients